T lymphocytes are central components of the adaptive immune system, tasked with recognising and responding to a wide array of antigens. Their activation is initiated through the engagement of the T ...
Morning Overview on MSN
Researchers map real-time signals that trigger T cell activation
A cluster of recent studies has sharpened the scientific picture of how T cells switch on, tracking the molecular signals ...
MPC-3100, a fully synthetic, orally bioavailable Hsp90 inhibitor, in cancer patients. Background: hTERT is expressed in 93% to 100% of NSCLC, making the enzyme a target for immunotherapy. Present ...
Development of a novel mouse model to delineate the role of tumor microenvironment on mechanism of action and efficacy of PD-1 and CTLA-4 checkpoint blockade. This is an ASCO Meeting Abstract from the ...
In recent years, significant progress has been made in tissue-based technology, opening up unparalleled opportunities for identifying disease process biomarkers and gaining invaluable insights. Among ...
Amyotrophic lateral sclerosis (ALS), formerly known as Lou Gehrig’s disease, is a progressive and fatal neurodegenerative disorder with no known cure. While three ...
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine ...
Lymphocytosis means you have a higher-than-usual lymphocyte count, often defined as more than 3 to 4 billion cells per liter of blood. Lymphocytes are white blood cells that help fight disease. Smudge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results